Does Apellis Pharmaceuticals sponsor H-1B workers?
VisaSignal shows official LCA filing activity found in the imported dataset. That activity can indicate historical immigration-related hiring signals, but it is not a promise of sponsorship.
Employer profile
Official filing activity, wage signals, roles, and source freshness in one place.
LCA
2
PERM
0
Median wage
$166,379
Last activity
Mar 31, 2026
Summary
Apellis Pharmaceuticals has filed two Labor Condition Applications (LCA) in FY2026 Q2, both of which have been certified. The top roles include Senior Manager, Distribution Operations and Senior Scientist, Translational Medicine, each representing 50% of the filings. The positions are located in Okemos, MI, and Waltham, MA. Salary statistics indicate a median annual salary of $166,379, with a range from $165,542 to $167,215. It's important to note that LCA certification does not guarantee USCIS H-1B petition approval, and there are no PERM filings reported. This information is not legal advice.
Sources
Employer filing context
Use this section for searches such as "Apellis Pharmaceuticals H-1B", "Apellis Pharmaceuticals LCA", and "Apellis Pharmaceuticals PERM" before comparing individual case rows.
Activity mix
2 LCA rows and 0 PERM rows are normalized to this employer.
Latest source period: FY2026 Q2.
Role and worksite signal
Top observed role: Senior Manager, Distribution Operations. Top worksite: Okemos, MI.
Compare this with the H-1B/LCA and PERM drill-down tabs before treating counts as a hiring signal.
Normalization and source check
Primary source: DOL OFLC disclosure data. Last verified: .
Filing trends
Roles
Worksites
Status mix
LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.
FAQ
VisaSignal shows official LCA filing activity found in the imported dataset. That activity can indicate historical immigration-related hiring signals, but it is not a promise of sponsorship.
The PERM count reflects imported DOL PERM disclosure rows for this normalized employer. Raw employer names and aliases are preserved so users can inspect normalization confidence.
For Apellis Pharmaceuticals H-1B research, the page summarizes imported DOL LCA labor-condition rows. For Apellis Pharmaceuticals PERM research, it summarizes imported DOL permanent labor certification rows. Both include roles, worksites, wage signals, case-status mix, and the latest source period.
No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.
No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.
No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.